Hui Li | Cardiothoracic Anesthesia | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hui Li | Cardiothoracic Anesthesia | Best Researcher Award

The Second Xiangya Hospital of Central South University | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Hui Li began her academic journey with a strong interest in internal medicine, which laid the foundation for her later specialization. Her doctoral studies at Central South University equipped her with in-depth knowledge of the mechanisms of disease progression and clinical applications. These formative years shaped her scientific curiosity and commitment to advancing research that bridges clinical practice and basic science.

Professional Endeavors

Prof. Li currently serves as the Associate Director of the Institute of Anesthesiology at Central South University, where she has taken on leadership responsibilities in guiding both clinical and academic teams. She has successfully secured competitive national research funding and has consistently contributed to the advancement of anesthesiology and perioperative medicine. Her role also extends to mentoring young researchers and postgraduate students, thereby strengthening the academic environment of her institution.

Contributions And Research Focus

Her primary research focus revolves around perioperative organ protection and neuro immune regulation. Prof. Li has explored the underlying biological mechanisms that influence patient outcomes during and after surgery, with an emphasis on protecting vital organs from damage. Her work highlights the intricate interaction between the nervous and immune systems in the perioperative setting, contributing valuable insights to both anesthesiology and internal medicine.

Impact And Influence

Prof. Li has published extensively in reputable international journals, including contributions to highly respected platforms such as Nature Communications, Cell Death and Disease, and Cardiovascular Diabetology. Through these publications, her findings have gained global recognition and have provided new directions for clinical research. Her influence extends beyond her own institution, as her research is frequently cited and built upon by other scholars in the field.

Academic Cites

The scholarly impact of Prof. Li is evident in the citations her work has received in the global academic community. Her contributions are referenced in multiple studies across anesthesiology, immunology, and cardiovascular research. This academic visibility underscores the relevance and applicability of her research in interdisciplinary domains.

Legacy And Future Contributions

Prof. Li’s academic legacy lies in her ability to connect molecular insights with practical clinical applications. Her work on organ protection and neuro immune pathways not only advances the field of anesthesiology but also has broader implications for perioperative care and long term patient recovery. Looking ahead, her continued leadership and innovative studies are expected to shape future standards in patient safety, anesthesia practices, and translational medicine.

Conclusion

Prof. Hui Li stands as a distinguished academic whose career reflects dedication to clinical innovation and scientific excellence. With her leadership in anesthesiology, her significant body of research, and her growing academic influence, she continues to contribute meaningfully to both scientific advancement and medical practice. Her trajectory promises further breakthroughs that will enhance patient outcomes and inspire future generations of researchers.

Notable Publications

"Random forest algorithm for predicting postoperative hypotension in oral cancer resection and free flap reconstruction surgery"

Authors: Shuiting Zhang, Yanling Zhang, Xinyu Ouyang, Hui Li , Ruping Dai
Journal: Scientific Reports
Year: 2025

"Monocytes perturbation implicated in the association of stress hyperglycemia with postoperative poor prognosis in non-diabetic patients with Stanford type-A acute aortic dissection"

Authors: Shuai Zhao, Di Fu, Wei Luo, Wei-Yun Shen, Xue-Mei Miao, Jia-Ying Li, Jing-Ying Yu, Qian Zhao, Hui Li, Ru-Ping Dai
Journal: Cardiovascular Diabetology
Year: 2024

Qiong Wu | Heart Failure | Best Paper Award

Published on by Cardiology and Cardiovascular Medicine

Assoc. Prof. Dr. Qiong Wu | Heart Failure | Best Paper Award

Longhua Hospital | Shanghai University of TCM | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qiong Wu began her academic journey in Traditional Chinese Medicine, completing her Bachelor’s degree in Acupuncture and Massage from Shanghai University of Traditional Chinese Medicine. She continued her education with a Master’s degree in Clinical Integrated Traditional Chinese and Western Medicine, further strengthening her expertise in bridging conventional and traditional medical practices. Her academic advancement culminated with a doctoral degree in Chinese Medicine, where she specialized in cardiovascular applications of integrated treatment approaches.

Professional Endeavors

Her professional trajectory has been closely linked with Longhua Hospital, affiliated to Shanghai University of Traditional Chinese Medicine. Beginning as a physician in multiple specialties including cardiology, neurology, respiratory medicine, nephrology, and endocrinology, she gained wide clinical exposure. Progressing into academic medicine, she served as an Assistant Professor in the Cardiovascular Department and is currently an Associate Professor in the same institution. These roles have allowed her to combine clinical service, academic teaching, and intensive research.

Contributions And Research Focus

Qiong Wu has accumulated nearly a decade of research experience centered on cardiovascular diseases such as dilated cardiomyopathy, ischemic heart disease, and hypertension. Her primary focus lies in pharmacological interventions, herb-drug interactions, and the integrated prevention of ventricular remodeling. She has developed specialized expertise in cardiomyocyte apoptosis, ventricular remodeling, and lymphatic vessel regeneration. She is proficient in advanced laboratory methodologies such as protein purification, RNA isolation, western blotting, immunohistochemistry, and cell culture, underscoring her capacity for translational cardiovascular research.

Impact And Influence

Her research has been recognized with competitive funding from prestigious sources, including the National Natural Science Foundation of China, the Shanghai Municipal Health Commission, and institutional programs at her university and affiliated hospital. These projects reflect both her leadership as a principal investigator and her commitment to bridging traditional medicine with modern biomedical science. Her contributions to clinical research include randomized, double-blind clinical studies on Traditional Chinese Medicine formulations for conditions such as atrial fibrillation and dilated cardiomyopathy.

Academic Cites

In addition to research articles, she has contributed significantly to scholarly literature through editorial roles. She has served as an associate editor for a comprehensive text on the integrated treatment of dilated cardiomyopathy and as a co-editor for a volume on chronic cor pulmonale. Her academic writings and publications not only disseminate knowledge but also serve as valuable references for the integration of traditional Chinese and Western medicine approaches in cardiovascular care.

Legacy And Future Contributions

Qiong Wu’s work exemplifies the convergence of clinical practice, experimental research, and traditional medicine innovation. Her patent applications on Chinese medicine compositions for atrial fibrillation and cardiomyopathy demonstrate her translational impact and potential for therapeutic innovation. As an active member of multiple professional committees within China, she is contributing to the shaping of national discourse on cardiovascular medicine, drug research, and clinical pharmacy in Traditional Chinese Medicine. Her legacy is likely to be defined by her role in validating and modernizing traditional formulations through rigorous clinical and experimental frameworks.

Conclusion

Qiong Wu stands out as an accomplished academician and researcher in the field of integrated cardiovascular medicine. With a strong foundation in both Traditional Chinese Medicine and modern biomedical approaches, she has advanced understanding in areas such as ventricular remodeling, herb-drug interactions, and clinical treatment of complex cardiovascular conditions. Her leadership in funded projects, editorial contributions, and patents positions her as an influential figure shaping the integration of traditional and contemporary practices. Looking forward, her ongoing research and clinical collaborations are expected to make lasting contributions to the global field of cardiovascular medicine.

Notable Publications

"Kuoxin Decoction Alleviated Left Ventricular Remodeling by Inhibiting Cardiomyocyte Apoptosis Through ASK1/JNK/Cx43 Signaling Pathway in cTnTR141W Transgenic Mice and in vitro"

Authors: Mengjiao Ma, Hua Fan, Yidan Dong, Tianyi Feng, Longping Peng, Maolin Zhou, Feifei Liu, RueyJyh Lee, Rongxue Wu, Qiong Wu et al.
Journal: Drug Design, Development and Therapy
Year: 2025

"Regulatory Effects of Zhenxin Formula in Treating Doxorubicin-Induced Heart Failure: Network Pharmacology and Animal Experimental Verification"

Authors: Qiong Wu, Hao Wang, You Wang, Jun Du, Bo Li, Xiao-Na Gan, Chen-Yang Liu, Jing Liang, Chang Liu, Min Cao
Journal: Drug Design, Development and Therapy
Year: 2025

"MMP3 at the Crossroads: Linking Molecular Pathways to Disease Diagnosis and Therapy"

Authors: Jing Jiang, Qiong Wu, Snekha Rajasekaran, Rongxue Wu
Journal: Pharmacological Research
Year: 2025

"Remote Ischaemic Pre-conditioning, Kidney Injury, and Outcomes After Coronary Angiography and Intervention: A Randomized Trial"

Authors: Ping Jia, Gang Zhao, Yuli Huang, Zhouping Zou, Qi Zeng, Weize Chen, Ting Ren, Yang Li, Xiaoyan Wang, Tingting Kang et al.
Journal: European Heart Journal
Year: 2025

"Astragalus Polysaccharide Protects Against Cardiac Injury in a tnnt2a Mutant Zebrafish Model of Dilated Cardiomyopathy"

Authors: Chang Zhou, Hui Zhao, Longping Peng, Yidan Dong, Qiong Wu, Xu Wang, Yingjia Xu, Youhua Wang
Journal: BMC Complementary Medicine and Therapies
Year: 2025

"Efficacy and Safety of Kuoxin Formula in the Treatment of Dilated Cardiomyopathy-Related Heart Failure: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial"

Authors: Qiong Wu, Shiying An, RueyJyh Lee, Dongwen Gao, Yinyifan Zhou, Longping Peng, Chunrui Hu, Lei Yao, Chang Zhou, Li Zhou et al.
Journal: International Journal of General Medicine
Year: 2024

"Comparison of Two Single-Pill Dual Combination Antihypertensive Therapies in Chinese Patients: A Randomized, Controlled Trial"

Authors: Qi-Fang Huang, Di Zhang, Yihong Luo, Kun Hu, Qiong Wu, Hailong Qiu, Fei Xu, Mei-Ling Wang, Xin Chen, Yan Li et al.
Journal: BMC Medicine
Year: 2024

"A Retrospective Study of Pupingqinghua Prescription Versus Lianhuaqingwen in Chinese Participants Infected With SARS-CoV-2 Omicron Variants"

Authors: Yidan Dong, Wei Zhai, Bangjiang Fang, Chenyang Liu, Suyun Yuan, Youhua Wang, Qixiang Song, Hai Li, Bin Chen, Dan Cui et al.
Journal: Frontiers in Pharmacology
Year: 2022

 

Mingfu Wu | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Mingfu Wu | Congenital Heart Defects | Best Researcher Award

University of Houston | United States

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Mingfu Wu began his academic journey with a strong commitment to biomedical sciences, developing a deep interest in the processes underlying heart development. His early pursuits were guided by curiosity and rigorous training, building a strong foundation in developmental biology and cardiovascular research. This period shaped his passion for investigating the molecular and cellular mechanisms that contribute to heart formation.

Professional Endeavors

Over the course of his career, Mingfu Wu has established himself as a respected researcher and academic leader. He has held important academic positions that allowed him to balance research, teaching, and scientific service. His professional journey reflects dedication to advancing knowledge, fostering collaboration, and contributing to the broader scientific community through peer review, academic service, and mentoring.

Contributions And Research Focus

The research focus of Mingfu Wu centers on uncovering the molecular mechanisms of cardiac development and disease. His pioneering studies have advanced understanding of trabecular morphogenesis, epicardial development, and the role of regulatory proteins in heart formation. His more recent discovery of tunneling nanotube-like structures that mediate long-distance intercellular communication highlights his ability to pursue groundbreaking directions in developmental biology.

Impact And Influence

The impact of Mingfu Wu’s work is evident in its wide recognition within the scientific community. His findings have provided critical insights that shaped further research in developmental cardiology, regenerative medicine, and related disciplines. Beyond his publications, his influence is visible in the success of students and postdoctoral researchers he has mentored, many of whom have been recognized for their contributions.

Academic Cites

Mingfu Wu’s research has been consistently cited by peers, underscoring its importance and relevance. His work has been presented at national and international conferences, incorporated into the academic dialogue of cardiovascular biology, and acknowledged in leading scientific journals. His contributions as a reviewer and evaluator for scholarly bodies further reflect the trust placed in his expertise.

Legacy And Future Contributions

Mingfu Wu’s legacy rests on his ability to combine innovative scientific discovery with impactful mentorship and academic service. Looking ahead, his future contributions are expected to move increasingly toward translational research, bridging the gap between basic biological understanding and clinical applications. Through continued interdisciplinary collaboration and mentorship, his work will leave a lasting imprint on cardiovascular research.

Conclusion

In conclusion, Mingfu Wu represents the qualities of a distinguished scholar and innovator. His research achievements, academic influence, and commitment to scientific advancement make him an outstanding candidate for the Best Researcher Award. With a legacy of impactful discoveries and a promising future of translational contributions, he stands as a leader whose work will continue to shape the field of cardiovascular and developmental biology.

Notable Publications

"Tunneling Nanotube-Like Structures Regulate Distant Cellular Interactions During Heart Formation"

Authors: Lianjie Miao, Yangyang Lu, Anika Nusrat, Guizhen Fan, Shaohua Zhang, Luqi Zhao, Chia-Ling Wu, Hongyan Guo, Trang Le Nu Huyen, Yi Zheng, Zhen-Chuan Fan, Weinian Shou, Robert J Schwartz, Yu Liu, Ashok Kumar, Haixin Sui, Irina I Serysheva, Alan R Burns, Leo Q Wan, Bin Zhou, Sylvia M Evans, Mingfu Wu*
Journal: Science
Year: 2025

"β1 Integrins Regulate Cellular Behaviors and Cardiomyocyte Organization During Ventricular Wall Formation"

Authors: Lianjie Miao, Yangyang Lu, Anika Nusrat, Luqi Zhao, Micah Castillo, Yongqi Xiao, Hongyang Guo, Yu Liu, Preethi Gunaratne, Robert J Schwartz, Alan R Burns, Ashok Kumar, C Michael DiPersio, Mingfu Wu*
Journal: Cardiovascular Research
Year: 2024

"The IRE1α/XBP1 Signaling Axis Drives Myoblast Fusion in Adult Skeletal Muscle"

Authors: Joshi AS, Tomaz da Silva M, Roy A, Koike TE, Wu M, Castillo MB, Gunaratne PH, Liu Y, Iwawaki T, Kumar A
Journal: EMBO Reports
Year: 2024

"Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice"

Authors: Sun B, Rouzbehani OMT, Kramer RJ, Ghosh R, Perelli RM, Atkins S, Fatahian AN, Davis K, Szulik MW, Goodman MA, Hathaway MA, Chi E, Word TA, Tunuguntla H, Denfield SW, Wehrens XHT, Whitehead KJ, Abdelnasser HY, Warren JS, Wu M, Franklin S, Boudina S, Landstrom AP
Journal: Circulation: Heart Failure
Year: 2023

"Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead"

Authors: Datta S, Cao W, Skillman M, Wu M*
Journal: International Journal of Molecular Sciences
Year: 2023

"Temporal Regulation of TAK1 to Counteract Muscular Dystrophy"

Authors: Anirban Roy, Tatiana Koike, Aniket Joshi, Meiricris Tomaz Da Silva, Kavya Mathukumalli, Mingfu Wu, Ashok Kumar
Journal: JCI Insight
Year: 2023

Dani Qin | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Dani Qin | Cardiovascular Disease | Best Researcher Award

Yixing People's Hospital | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qin Dani began her academic journey with a strong foundation in pediatrics, completing her studies at a prestigious medical university and further pursuing advanced training. Her dedication to continuous learning is evident as she continues doctoral studies at a reputed university. Her academic background laid the groundwork for her clinical expertise and research orientation in pediatric healthcare.

Professional Endeavors

She has established herself as a key figure in the Department of Pediatrics at Yixing People's Hospital, where she has been contributing her expertise for many years. During her career, she also pursued advanced studies and training at well-regarded medical institutions, which broadened her clinical skills and enriched her professional development. She currently holds a leadership role as an Associate Chief Physician and plays an active part in pediatric development teams, shaping the direction of child healthcare services.

Contributions and Research Focus

Her clinical work spans the diagnosis and treatment of a wide spectrum of pediatric conditions, with particular strengths in infant and toddler health care, respiratory disorders, digestive system diseases, and neonatal health management. She has led several important research projects at provincial and municipal levels, demonstrating her commitment to bridging clinical practice with academic research. Her published works reflect a dedication to advancing pediatric medicine through evidence-based studies and practical insights.

Impact and Influence

Through her leadership and expertise, she has significantly contributed to improving pediatric care standards in her community and beyond. Her ability to manage both common and critical pediatric illnesses has earned her recognition among colleagues and institutions alike. Her influence extends to mentoring young professionals, thereby fostering the next generation of pediatric specialists.

Academic Cites

She has authored numerous academic publications in both international and national journals, with multiple contributions recognized in core and indexed platforms. Her scholarly work has been acknowledged through prestigious awards in natural science and academic excellence, showcasing her impact in both scientific and clinical communities.

Legacy and Future Contribution

Her career trajectory reflects a deep commitment to pediatric medicine, both in clinical practice and academic advancement. With her ongoing doctoral research, she is expected to make further strides in pediatric healthcare innovations. Her legacy will likely continue through her contributions to research, her role in nurturing young professionals, and her influence on public health standards in pediatrics.

Recognition and Honors

She has received several commendations from healthcare authorities and academic institutions for her outstanding contributions, including recognition for advanced individual achievements and excellence in academic publications. These accolades highlight her dedication, professionalism, and long-term impact in the medical field.

Conclusion

Qin Dani exemplifies the qualities of an accomplished physician, researcher, and academic leader. Her blend of clinical expertise, research achievements, and commitment to advancing pediatric medicine has left a lasting mark on both medical practice and scientific scholarship. With a proven record of excellence and continued pursuit of innovation, she stands as a role model in the field of pediatrics, poised to make even greater contributions in the years ahead.

Notable Publications

"Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen‐activated protein kinase signaling pathway"

Authors: Dani Qin; Yong Lei; Wen Xie; Qiuju Zheng; Zhou Peng; Yiwen Liu; Biao Dai; Tieliang Ma; Ping
Journal: Cell Biology
Year: 2023

"Effects of miR-19b Overexpression on Proliferation, Differentiation, Apoptosis and Wnt/β-Catenin Signaling Pathway in P19 Cell Model of Cardiac Differentiation In Vitro"

Authors: Da-Ni Qin; Lingmei Qian; De-Liang Hu; Zhang-Bin Yu; Shu-Ping Han; Chun Zhu; Xuejie Wang;
Journal: Cell Biochemistry and Biophysics
Year: 2013